This webinar aims to teach healthcare professionals, both at a primary and specialist level a multidisciplinary approach towards managing young women with breast cancer, both in the early and advanced setting.
Join us for a unique opportunity to look at the multifaceted approach towards young women with breast cancer, looking at the latest data from world-leading experts both at the treatment and support of women in these positions. This session will provide a multidisciplinary approach as well as an evaluation of the science and latest advances in the interpretation of this data.
In an interactive setting, we will be focusing on the latest updates on the scientific, clinical and psychosocial aspects of breast cancer in young women and the multidisciplinary management of the disease.
This webinar is for healthcare professionals only.
Learning objectives for the participants:
A CPD certificate with 6 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed
We would like to thank our sponsors AstraZeneca & Daiichi Sankyo, Novartis, Pierre-Fabre Ltd and Roche for their support of this webinar. Promotional symposium organised by Daiichi Sakyo and AstraZeneca is intended for Healthcare professionals.
Please note that the scientific programme and content has not been influenced in any way by the sponsors.
Dr Marina Parton and Dr Bhawna Sirohi
Dr Bhawna Sirohi
Dr Fatima Cardoso, Director, Breast Unit, Champalimaud Clinical Centre, President ABC Global Alliance, Lisbon, Portugal
Kisqali and the treatment of pre-menopausal women – presentation by Novartis, given by Dr Mark Tuthill, Consultant Medical Oncologist, The Churchill Hospital, Oxford
Chair: Mr Henry Cain
Dr Helen Hanson, Consultant in Cancer Geneticist, St George's, University Hospital NHS Foundation Trust
Dr Zoe Kemp, Consultant Geneticist, Royal Marsden Hospital
Chair: Dr Susie Stanway
Dr Yuliya Kopeika, Consultant Gynaecologist, Subspecialist in Reproductive medicine Guy's and St Thomas' Hospital NHS Foundation Trust
Redefining expectations in third-line HER2+ metastatic breast cancer (mBC); given by Dr Alicia Okines, Consultant Medical Oncologist, from The Royal Marsden hospital.
Promotional symposium organised by Daiichi Sankyo and AstraZeneca is intended for HCPs only. Daiichi Sankyo and AstraZeneca have had no other involvement into the other aspects of this meeting
Chair: Dr Marina Parton
Dr Shaheenah Dawood, Head of Medical Oncology, Head of the Breast Cancer Program, Dubai, UAE
Professor Andrew Tutt, Head of Division, Breast Cancer Research, The Institute of Cancer Research, Director of the Breast Cancer Now Research Centre, Institute of Cancer Research, and Breast Cancer Now Research Unit, Kings College London, Clinician Scientist, Consultant Clinical Oncologist in Breast Cancer
Addressing Health Disparities in Breast Cancer Clinical Research – presentation by Roche, given by Ed Merivale & Howard Turner
Chair: Dr Richard Simcock
Dr Caroline Wilson, Consultant Medical Oncologist Weston Park Cancer Centre, Sheffield, Honorary Clinical Senior Lecturer UoS and Dr Catherine Harper-Wynne, Consultant Medical Oncologist and Honorary Senior Lecturer University of Kent
Dr Clare Shaw, Consultant Dietician, The Royal Marsden NHS Foundation Trust
Dr Stuart Anderson, Consultant Neuropsychologist, Independent Practice and Health and Social Care Directorate, States of Guernsey
Mr Ben Smith, CONCERT Co-Deputy Director (Policy and Practice) Conjoint Senior Lecturer, UNSW Sydney
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
